A Clinical Trial to Study The Effect of Haritaki and Nimba Choorn in Dadru Roga

A pharmaco-therapeutic action of Haritaki (Terminalia chebula) and Nimba (Azadirachta indica) in Dadru roga. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067531

Enrollment

Registered

2024-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing for trial and give written informed consent. 2.Patient having classical feature of Dadru Kustha will be included. 3.The age group of patients will be between 20-60 yrs.

Exclusion criteria

Exclusion criteria: 1.Patient suffering from diseases like AIDS, Cancer, TB, Cardiac problems etc. 2.Patient suffering from systemic disorder like Diabetes, Renal stricture, hepatic disorder is excluded. 3.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Reduction in symptoms of Dadru (Tinea corporis)Timepoint: 30 days	—

Secondary

Measure	Time frame
1.To assess the Effectiveness of Haritaki churn in Kandu, Raaga, Mandala 2.To assess the Effectiveness of Nimba churn in Kandu,Raaga,Mandala 3.To compare the Effectiveness of Haritaki churn & Nimba churn in Kandu, Raaga & MandalaTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Sampurna Nand Tiwari

Goverment Ayurvedic College and Hospital Patna Bihar

dtiwariayurved@gmail.com7903144598

Outcome results